Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL137920, R01 HL130093, R21 HL126015)
Received: 12 January 2018
Accepted: 1 February 2018
First Online: 19 February 2018
: The prospective volunteer study (<i>n</i> = 8) was approved by the NorthShore University HealthSystem Institutional Review Board (IRB).
: Consent for publication of their individual details and accompanying images in this manuscript was prospectively provided in 8 subjects. No protected health information for any subject is given in this manuscript.
: RE: Research support and invention licensing agreement, Siemens Healthcare. Inventor on patent application describing the fast interrupted steady-state technology, and holds patents for QISS.JP: Employee, Siemens Healthcare.IK: Inventor on patent application describing the fast interrupted steady-state technology.There were no non-financial conflicts of interest for any of the authors.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.